~~<i id='2B7FFF0574'><strike id='2B7FFF0574'><tt id='2B7FFF0574'><pre id='2B7FFF0574'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

fashion

author：leisure time 2025-09-28 22:53:35 - browse：43

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Generate Biomedicines machine learning biotech raises $273M

hotspot

leisure time

entertainment

Wikipedia

Illustration:ChristineKao/STAT;Photos:Getty,AP,AdobeTheH5N1birdfluvirushasbeenaroundfordecades,andth

WSS

WATCH: Why do bright lights make us see spots?

Study: AI not yet building 'n

Telehealth startups turn to complex chronic diseases

After gene therapy, two congenitally deaf children hear for the first time

Telehealth for opioid use disorder is lifesaving

Popular nasal decongestant doesn't actually relieve congestion

entertainment

fashion

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

What to make of Biden’s latest efforts on cancer research

Heart attack and stroke risk calculators need revising

Will the IRA bring competition to the biologics market?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Private equity could exacerbate cardiology's overuse problem, experts fear

FDA approval of Sarepta Duchenne genetic therapy gives me hope

White House touts steps to stem shortages of cancer treatments

How to save PrEP access — and even expand it

Hospitals consider fixing cancer drug shortages on their own

leisure time

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Generate Biomedicines machine learning biotech raises $273M

Steward Health Care files for bankruptcy

Regeneron agrees to White House price limits on anti

Regeneron agrees to White House price limits on anti

Generate Biomedicines machine learning biotech raises $273M

entertainment

Wikipedia

Wikipedia

Wikipedia